BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34626574)

  • 21. [Isolated primary vitreoretinal lymphoma (case report)].
    Stoyukhina AS; Korobov EN; Smolin SA
    Vestn Oftalmol; 2024; 140(2. Vyp. 2):94-101. PubMed ID: 38739137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitreoretinal Lymphoma: A Literature Review and Introduction of a New Diagnostic Method.
    Takhar J; Doan T; Gonzales JA
    Asia Pac J Ophthalmol (Phila); 2021 Jan; 10(1):93-98. PubMed ID: 33481398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Consensus Recommendations for the Diagnosis of Vitreoretinal Lymphoma.
    Carbonell D; Mahajan S; Chee SP; Sobolewska B; Agrawal R; Bülow T; Gupta V; Jones NP; Accorinti M; Agarwal M; Batchelor T; Biswas J; Cimino L; tenDam-van Loon NH; de-la-Torre A; Frenkel S; Pe'er J; Kramer M; Miserocchi E; Mochizuki M; Ness T; Rosenbaum JT; Sen HN; Simion M; Sitter H; Vasconcelos-Santos DV; Habot-Wilner Z; Coupland SE; Pulido JS; Smith J; Thorne JE; Zierhut M;
    Ocul Immunol Inflamm; 2021 Apr; 29(3):507-520. PubMed ID: 34009095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitreoretinal presentation of secondary large B-cell lymphoma in patients with systemic lymphoma.
    Salomão DR; Pulido JS; Johnston PB; Canal-Fontcuberta I; Feldman AL
    JAMA Ophthalmol; 2013 Sep; 131(9):1151-8. PubMed ID: 23744124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic methods for primary vitreoretinal lymphoma: A systematic review.
    Huang RS; Mihalache A; Popovic MM; Cruz-Pimentel M; Pandya BU; Muni RH; Kertes PJ
    Surv Ophthalmol; 2024; 69(3):456-464. PubMed ID: 38163550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DIFFERENTIAL DIAGNOSIS FOR VITREORETINAL LYMPHOMA WITH VITREORETINAL FINDINGS, IMMUNOGLOBULIN CLONALITY TESTS, AND INTERLEUKIN LEVELS.
    Lee J; Kim SW; Kim H; Lee CS; Kim M; Lee SC
    Retina; 2019 Jun; 39(6):1165-1176. PubMed ID: 29474309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Relevance of the High Prevalence of MYD88 L265P Mutated Vitreoretinal Lymphoma Identified by Droplet Digital Polymerase Chain Reaction.
    Shi H; Zhou X; Chen B; Xiao J; Li Y; Zhou X; Zhou Q; Chen K; Wang Q
    Ocul Immunol Inflamm; 2021 Apr; 29(3):448-455. PubMed ID: 31603365
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunohistochemical and Immunocytochemical Analyses in Patients with Vitreoretinal Lymphoma.
    Kase S; Namba K; Kanno-Okada H; Onozawa M; Hidaka D; Iwata D; Mizuuchi K; Fukuhara T; Fukuhara J; Kitaichi N; Matsuno Y; Ishida S
    Ocul Immunol Inflamm; 2020; 28(1):147-155. PubMed ID: 30335535
    [No Abstract]   [Full Text] [Related]  

  • 29. Combined cellular and soluble mediator analysis for improved diagnosis of vitreoretinal lymphoma.
    de Hoog J; Dik WA; Lu L; Heezen KC; Ten Berge JC; Swagemakers SMA; van der Spek PJ; van Dongen JJM; van der Velden VHJ; Rothova A; Langerak AW
    Acta Ophthalmol; 2019 Sep; 97(6):626-632. PubMed ID: 30688042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Features and Treatment Outcomes of Vitreoretinal Lymphoma according to Its Association with CNS Lymphoma.
    Cho BJ; Kim DY; Park UC; Lee JY; Yoon YH; Yu HG
    Ocul Immunol Inflamm; 2018; 26(3):365-371. PubMed ID: 29394118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell-Free DNA Extraction of Vitreous and Aqueous Humor Specimens for Diagnosis and Monitoring of Vitreoretinal Lymphoma.
    Brown NA; Rao RC; Betz BL
    J Vis Exp; 2024 Jan; (203):. PubMed ID: 38284545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary vitreoretinal natural killer/T-cell lymphoma with breast involvement: A case report and review of the literature.
    Gao S; Zhou Y; Jin X; Lin Z; Zhong Y; Shen X
    Surv Ophthalmol; 2019; 64(2):225-232. PubMed ID: 30321569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis of intraocular lymphoma.
    Davis JL
    Ocul Immunol Inflamm; 2004 Mar; 12(1):7-16. PubMed ID: 15209459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comment on Rie Tanaka et al.'s "Diagnosis of Vitreoretinal Lymphoma Using a Combination of Diagnostic Test Results".
    Zhang X; Zhang Y; Zhang W; Zhang M
    Ocul Immunol Inflamm; 2023 Jul; 31(5):1111. PubMed ID: 35998315
    [No Abstract]   [Full Text] [Related]  

  • 35. Aurora borealis and string of pearls in vitreoretinal lymphoma: patterns of vitreous haze.
    Marchese A; Miserocchi E; Giuffrè C; Cicinelli MV; Querques G; Bandello F; Modorati G
    Br J Ophthalmol; 2019 Nov; 103(11):1656-1659. PubMed ID: 30709808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenges in the diagnosis and management of vitreoretinal lymphoma - Clinical and basic approaches.
    Takase H; Arai A; Iwasaki Y; Imai A; Nagao T; Kawagishi M; Ishida T; Mochizuki M
    Prog Retin Eye Res; 2022 Sep; 90():101053. PubMed ID: 35210172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AN UNUSUAL CASE OF PRIMARY VITREORETINAL LYMPHOMA: A TRANSFORMED LYMPHOMA.
    Ustaoglu M; Patel R; Wang W; Shah S; Barr C
    Retin Cases Brief Rep; 2024 Mar; 18(2):181-183. PubMed ID: 36730965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic value of genetic mutation analysis and mutation profiling of cell-free DNA in intraocular fluid for vitreoretinal lymphoma.
    Chen X; Hu Y; Su W; Yang S; Wang X; Zhang P; Hong X; Liang C; Qian Z; Li Z; Tao Y; Huang H; Liang D
    Cancer Commun (Lond); 2022 Nov; 42(11):1217-1221. PubMed ID: 35920016
    [No Abstract]   [Full Text] [Related]  

  • 39. Distinct Profiles of Soluble Cytokine Receptors Between B-Cell Vitreoretinal Lymphoma and Uveitis.
    Takeda A; Yoshikawa H; Fukuhara T; Hikita S; Hijioka K; Otomo T; Arita R; Hisatomi T; Kimura K; Yoshida S; Kawano Y; Sonoda KH; Ishibashi T
    Invest Ophthalmol Vis Sci; 2015 Nov; 56(12):7516-23. PubMed ID: 26595610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Features of Retinitis-like Lesions in Vitreoretinal Lymphoma.
    Marchese A; Agarwal A; Miserocchi E; Giuffrè C; Bandello F; Modorati G; Prakash G; Gupta N; Bosello F; Sharma SP; Gupta V
    Ocul Immunol Inflamm; 2021 Apr; 29(3):440-447. PubMed ID: 31567000
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.